通过CCR10促进T细胞贩运,以改善瘤免疫治疗
Jong Moo Hong1,2, Byung-Kwan Jeong1, Doyeon Han1,2
1Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Anticancer research
|February 2, 2024
概括
通过增强T细胞透来改善固体瘤的采用T细胞疗法. 在临床前模型中,用CCR10受体工程T细胞改善了瘤向和减少了瘤负担.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 固体瘤的采用T细胞疗法由于T细胞透不良,其疗效有限.
- 瘤特异性化学因受体提供了一种增强T细胞瘤定位的策略.
研究的目的:
- 为了研究化学因子受体CCR10在改善固体瘤中T细胞透的潜力.
- 为了生成和评估CCR10工程T细胞以增强抗瘤活性.
主要方法:
- 使用TCGA数据分析了T细胞和癌症中的化学因受体和连接体表达.
- 生成的 1G4 T 细胞受体工程 T (TCR-T) 细胞表达 CCR10.
- 对工程TCR-T细胞进行了体外和体内疗效研究.
主要成果:
- 在自然T细胞中,CCR10的表达是有限的,但其配体CCL28在乳腺癌和肺癌中升高.
- CCR10-1G4 TCR-T细胞在体外移动性增加和可比的细胞毒性.
- 在体内研究表明,通过CCR10-1G4 TCR-T细胞增强了贩运和显著减少了瘤负担.
结论:
- CCR10作为增强基于T细胞的癌症免疫疗法的目标具有前途.
- 表达CCR10的工程T细胞可以改善贩运和对固体瘤的疗效.
关键词:
1G4 1G4 1G4 1G4 1G4 的意思是什么意思CCL28 CCL28 CCL28 CCL28 CCL28 CCL28 CCL28 CCL28CCR10 CCR10 是一个很好的方法.化学物质化学物质是化学物质.在TCR-T细胞中.化学因子受体的化学因子受体更多相关视频
09:53Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
Published on: February 6, 2017
11.5K
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.4K
相关概念视频
Tumor Immunotherapy
526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
T Cell Activation and Clonal Selection
735
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
735
Cytotoxic T Cells-mediated Immune Response
917
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
917
